Recent progress on the versatility of virus-like particles

C Qian, X Liu, Q Xu, Z Wang, J Chen, T Li, Q Zheng… - Vaccines, 2020 - mdpi.com
Virus-like particles (VLPs) are multimeric nanostructures composed of one or more structural
proteins of a virus in the absence of genetic material. Having similar morphology to natural …

What does plant-based vaccine technology offer to the fight against COVID-19?

S Rosales-Mendoza, VA Márquez-Escobar… - Vaccines, 2020 - mdpi.com
The emergence of new pathogenic viral strains is a constant threat to global health, with the
new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS …

An overview of nanocarrier-based adjuvants for vaccine delivery

KC Petkar, SM Patil, SS Chavhan, K Kaneko… - Pharmaceutics, 2021 - mdpi.com
The development of vaccines is one of the most significant medical accomplishments which
has helped to eradicate a large number of diseases. It has undergone an evolutionary …

Plant molecular farming of virus‐like nanoparticles as vaccines and reagents

EP Rybicki - Wiley Interdisciplinary Reviews: Nanomedicine …, 2020 - Wiley Online Library
The use of plants for the production of virus‐like nanoparticles (VNPs) dates back to
separating natural empty capsids of plant viruses from whole virions nearly 70 years ago …

Contributions of the international plant science community to the fight against human infectious diseases–part 1: epidemic and pandemic diseases

M Lobato Gomez, X Huang, D Alvarez… - Plant Biotechnology …, 2021 - Wiley Online Library
Infectious diseases, also known as transmissible or communicable diseases, are caused by
pathogens or parasites that spread in communities by direct contact with infected individuals …

Plant-derived human vaccines: recent developments

J Stander, S Mbewana, AE Meyers - BioDrugs, 2022 - Springer
The idea of producing vaccines in plants originated in the late 1980s. Initially, it was
contemplated that this notion could facilitate the concept of edible vaccines, making them …

Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2

F Hemmati, M Hemmati-Dinarvand, M Karimzade… - Biotechnology …, 2022 - Springer
After its emergence in late 2019 SARS-CoV-2 was declared a pandemic by the World Health
Organization on 11 March 2020 and has claimed more than 2.8 million lives. There has …

Nanovaccine delivery approaches and advanced delivery systems for the prevention of viral infections: from development to clinical application

AS Cordeiro, Y Patil-Sen, M Shivkumar, R Patel… - Pharmaceutics, 2021 - mdpi.com
Viral infections causing pandemics and chronic diseases are the main culprits implicated in
devastating global clinical and socioeconomic impacts, as clearly manifested during the …

[HTML][HTML] Combating human viral diseases: will plant-based vaccines be the answer?

S Venkataraman, K Hefferon, A Makhzoum… - Vaccines, 2021 - mdpi.com
Molecular pharming or the technology of application of plants and plant cell culture to
manufacture high-value recombinant proteins has progressed a long way over the last three …

Mutation profile of HPV16 L1 and L2 genes in different geographic areas

D Tsakogiannis, M Nikolaidis, F Zagouri, E Zografos… - Viruses, 2022 - mdpi.com
The causal relationship between HPV and cervical cancer in association with the high
prevalence of high risk HPV genotypes led to the design of HPV vaccines based on the …